Wockhardt Revenue and Competitors

Mumbai, IND

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Wockhardt's estimated annual revenue is currently $864M per year.(i)
  • Wockhardt's estimated revenue per employee is $100,500

Employee Data

  • Wockhardt has 8597 Employees.(i)
  • Wockhardt grew their employee count by -1% last year.

Wockhardt's People

NameTitleEmail/Phone
1
Associate VP - Global Regulatory AffairsReveal Email/Phone
2
Head Supply Chain ManagementReveal Email/Phone
3
HR OfficerReveal Email/Phone
4
sr officer microbiologyReveal Email/Phone
5
general counselReveal Email/Phone
6
Sr officerReveal Email/Phone
7
VP & Head Corporate Strategy, M&A and Business DevelopmentReveal Email/Phone
8
ManagerReveal Email/Phone
9
Senior Manager ITReveal Email/Phone
10
Assistant ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$56.6M56321%N/AN/A
#2
$15.6M15528%N/AN/A
#3
$17M169-11%N/AN/A
#4
$13.2M1318%N/AN/A
#5
$19.6M19510%N/AN/A
#6
$23.5M2347%N/AN/A
#7
$5.3M530%N/AN/A
#8
$13M129-25%N/AN/A
#9
$20.5M20411%N/AN/A
#10
$11.7M1166%N/AN/A
Add Company

What Is Wockhardt?

Wockhardt is a global pharmaceutical and biotechnology organisation, providing affordable, high-quality medicines for a healthier world. It is India's leading research-based global healthcare enterprise with relevance in the fields of Pharmaceuticals, Biotechnology and a chain of advanced Super Speciality Hospitals. Wockhardt is a true Indian Multi-National Company with a multi-ethnic workforce of 8600 Wockhardt Associates from 21 different nationalities globally. It has 3 research centres and 12 manufacturing plants, with businesses ranging from the manufacture and marketing of Pharmaceutical and Bio-pharmaceutical formulations, Active Pharmaceutical Ingredients (APIs) and Vaccines. Headquatered in Mumbai, India, Wockhardt has full-fledged operations in the USA, UK, Ireland and France. It also has its marketing presence in emerging markets of Russia, Brazil, Mexico, Vietnam, Philippines, Nigeria, Kenya, Ghana, Tanzania, Uganda, Nepal, Myanmar, Sri Lanka, Mauritius, Lebanon and Kuwait. Wockhardt's core business is innovation. It uses science and technology to develop medicines and other products that improve the quality of millions people's lives through better health. Wockhardt aspires to create a healthier world. Its strategic vision of ‘More & More with Less & Less' has transformed into new ways of thinking, a new journey for growth, medical breakthroughs for patients and continuing value for all stakeholders.

keywords:N/A

N/A

Total Funding

8597

Number of Employees

$864M

Revenue (est)

-1%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Wockhardt News

2022-04-20 - Quinine Sulphate Market Size, Scope And Outlook | Actavis ...

Actavis, Wockhardt, Shreeji Pharma International, A. B. Enterprises, Caraco Pharmaceutical Laboratories, Aecochem Corp, Hangzhou Dayang Co.

2022-03-30 - Rakesh Jhujhunwala ups stake in this PSB, trims holding in Wockhardt

Wockhardt came up with a rights issue of Rs 748 crores to the issue of up to 3.32 crore rights equity shares at Rs 225 per share. The company...

2022-03-22 - 37%of this Wockhardt Limited (NSE:WOCKPHARMA) insider's holdings were sold in the last year

Wockhardt Insider Transactions Over The Last Year. The insider, Mahesh Patel, made the biggest insider sale in the last 12 months. That single...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$840.8M9240-7%N/A
#2
$933.4M95245%N/A
#3
N/A99433%N/A
#4
$1005.1M10256N/AN/A
#5
$1.7M1087410%N/A